Confirming positive results of nucleic acid amplification tests (NAATs) for Chlamydia trachomatis:: All NAATs are not created equal

被引：48

作者：

Schachter, J

Hook, EW

Martin, DH

Willis, D

Fine, P

Fuller, D

Jordan, J

Janda, WM

Chernesky, M

机构：

[1] Univ Calif San Francisco, Dept Lab Med, Chlamydia Res Lab, San Francisco, CA 94110 USA

[2] Univ Alabama, Birmingham, AL USA

[3] Louisiana State Univ, Med Ctr, New Orleans, LA USA

[4] Florida State Dept Hlth, Jacksonville, FL USA

[5] Planned Parenthood Fdn Houston & SE Texas, Houston, TX USA

[6] Wishard Mem Hosp, Indianapolis, IN USA

[7] Magee Womens Res Inst, Pittsburgh, PA USA

[8] Univ Illinois, Chicago, IL USA

[9] St Josephs Hlth Care Reg Virol & Chlamydiol Lab, Hamilton, ON, Canada

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2005年 / 43卷 / 03期

关键词：

D O I：

10.1128/JCM.43.3.1372-1373.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The Centers for Disease Control and Prevention recommended confirming positive screening tests for Chlamydia trachomatis when positive predictive values are < 90%. It is accepted that less sensitive tests (i.e., culture and immunoassays) should not be used to confirm the results of more sensitive nucleic acid amplification tests (NAATs). We show that the same principle applies when NAATs are used for confirmation.

引用

页码：1372 / 1373

页数：2

共 9 条

[1]

[Anonymous], MMWR RECOMM REP

[2] Accuracy of results obtained by performing a second ligase chain reaction assay and PCR analysis on urine samples with positive or near-cutoff results in the LCx test for Chlamydia trachomatis [J].